ArticleMedicine2026
Kartagener syndrome with pulmonary mycetoma and recurrent thromboembolism: A case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleKartagener syndrome, a variant of primary ciliary dyskinesia, is defined by chronic sinusitis, bronchiectasis, and situs inversus. While recurrent infections are seen, a combination of thromboembolic disease, pulmonary mycetoma, cardiac dysfunction, and serological evidence of autoimmune disorders is very uncommon. PATIENT CONCERNS: A 27-year-old man with Kartagener syndrome and situs inversus totalis complaining of worsening dyspnea, chest pain, fever, hemoptysis, and ankle swelling. His past medical history included episodes of deep vein thrombosis, recurrent pulmonary embolism, and chronic productive cough. DIAGNOSES: Radiologic studies showed dextrocardia, a right upper lobe cavitary lesion indicative of pulmonary mycetoma, hepatic congestion, and ascites. The echocardiogram demonstrated severe dysfunction of both left and right ventricles, a thrombus in the right ventricle, mild-moderate pericardial effusion, and an ejection fraction of about 40%. BNP was elevated, and U1-ribonucleoprotein antibodies were positive, implying a probable overlap of autoimmune disease, but diagnostic criteria were not fulfilled.
interventionsHe was prescribed appropriate heart failure management, anticoagulant therapy, antifungals, and multidisciplinary treatment of other issues. OUTCOMES AND LESSONS: The patient underwent adequate management of his cardiopulmonary, infectious, and thromboembolic complications. The existence of a causal link between these diseases could not be found. This case underscores the need for a multidisciplinary approach in evaluating patients with a combination of congenital and acquired systemic diseases. The association of Kartagener syndrome, pulmonary mycetoma, thromboembolic tendency, right ventricular thrombus formation, cardiac dysfunction, and positive U1-RNP is an unusual combination and calls for proper evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.